Evidence map›Paper›PMID 41288692›Full record

ArticleEuropean journal of nuclear medicine and molecular imaging2026

Potential value of [

Kim M Pabst, Sophie C Siegmund, Adrien Holzgreve, Hans P Schmid, Timo Bartel, Ken Herrmann, Alina T Küper, Can Aydogdu, David Kersting, Claudia Kesch and 8 more

Abstract readMulticenter Study
In one paragraph

Article in European journal of nuclear medicine and molecular imaging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. [European journal of nuclear medicine and molecular imaging · 2026
    Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Kim M Pabst *Department of Nuclear Medicine, West German Cancer Centre, University Hospital Essen, Hufelandstraße 55, Essen, 45147, Germany. kim.pabst@uk-essen.de.ORCID 0000-0002-9234-0795
Sophie C Siegmund *Department of Nuclear Medicine, LMU University Hospital, LMU Munich, Munich, Germany.
Adrien HolzgreveDepartment of Nuclear Medicine, LMU University Hospital, LMU Munich, Munich, Germany.
Hans P SchmidDepartment of Nuclear Medicine, LMU University Hospital, LMU Munich, Munich, Germany.
Timo BartelDepartment of Nuclear Medicine, West German Cancer Centre, University Hospital Essen, Hufelandstraße 55, Essen, 45147, Germany.
Ken HerrmannDepartment of Nuclear Medicine, West German Cancer Centre, University Hospital Essen, Hufelandstraße 55, Essen, 45147, Germany.
Alina T KüperDepartment of Nuclear Medicine, West German Cancer Centre, University Hospital Essen, Hufelandstraße 55, Essen, 45147, Germany.
Can AydogduDepartment of Urology, University Hospital, LMU Munich, Munich, Germany.
David KerstingDepartment of Nuclear Medicine, West German Cancer Centre, University Hospital Essen, Hufelandstraße 55, Essen, 45147, Germany.
Claudia KeschGerman Cancer Consortium, Partner Site University Hospital Essen, Essen, Germany.
Boris A HadaschikGerman Cancer Consortium, Partner Site University Hospital Essen, Essen, Germany.
Marcus UnterrainerDIE RADIOLOGIE, Munich, Germany.
Christian G StiefDepartment of Urology, University Hospital, LMU Munich, Munich, Germany.
Clemens C CyranDepartment of Radiology, LMU University Hospital, LMU Munich, Munich, Germany.
Rudolf A WernerDepartment of Nuclear Medicine, LMU University Hospital, LMU Munich, Munich, Germany.
Wolfgang P FendlerDepartment of Nuclear Medicine, West German Cancer Centre, University Hospital Essen, Hufelandstraße 55, Essen, 45147, Germany.
Jozefina Casuscelli *Department of Urology, University Hospital, LMU Munich, Munich, Germany.
Lena M Unterrainer *Department of Nuclear Medicine, LMU University Hospital, LMU Munich, Munich, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purpose[

methodsPatients with metastatic UC undergoing [

resultsThirty-four patients underwent [

conclusion[

Indexed as

Positron Emission Tomography Computed TomographyUrologic NeoplasmsAdultAgedAged, 80 and overFemaleFluorodeoxyglucose F18Gallium RadioisotopesHumansMaleMiddle AgedNeoplasm MetastasisQuinolinesRetrospective Studies68Ga-FAPIFluorodeoxyglucose F18Gallium RadioisotopesQuinolines2-[18F]FDG-PET[68Ga]Ga-FAPI-46 PETCeCTDetection efficacyUrothelial carcinoma

Identifiers

PMID41288692
PMCPMC13013314

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.